Haemonetics Appoints Frank Chan As Executive Vice President, Chief Operating Officer; Roy Galvin As Executive Vice President, Chief Commercial Officer
Mar 03, 2025•6 months ago
Position
Chief Operating Officer
Company
Haemonetics
Description
Haemonetics Corporation announced the appointment of Frank Chan, Ph.D. as Executive Vice President, Chief Operating Officer effective April 7, 2025, and the appointment of Roy Galvin as the company's Executive Vice President, Chief Commercial Officer, effective immediately.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months